Compare VANI & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VANI | GPOR |
|---|---|---|
| Founded | 1998 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.0M | 3.5B |
| IPO Year | 2014 | 1998 |
| Metric | VANI | GPOR |
|---|---|---|
| Price | $1.17 | $161.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $3.50 | ★ $233.33 |
| AVG Volume (30 Days) | 151.4K | ★ 255.6K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 245.92 |
| EPS | N/A | ★ 8.87 |
| Revenue | $4,000,000.00 | ★ $1,422,583,000.00 |
| Revenue This Year | N/A | $18.35 |
| Revenue Next Year | N/A | $6.04 |
| P/E Ratio | ★ N/A | $17.97 |
| Revenue Growth | N/A | ★ 48.47 |
| 52 Week Low | $0.92 | $158.91 |
| 52 Week High | $1.92 | $225.78 |
| Indicator | VANI | GPOR |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 38.48 |
| Support Level | $1.13 | N/A |
| Resistance Level | $1.25 | $172.13 |
| Average True Range (ATR) | 0.06 | 4.47 |
| MACD | 0.00 | 0.43 |
| Stochastic Oscillator | 50.00 | 24.06 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets located in the Appalachia and Anadarko basins in the United States. The principal properties of the company are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.